Statements of Changes in Shareholders’ Deficit - USD ($)		Class A Ordinary Shares	Class B Ordinary Shares	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Aug. 15, 2024
Balance (in Shares) at Aug. 15, 2024
Issuance of Founder Shares to Sponsor	[1]		$ 719	24,281		25,000
Issuance of Founder Shares to Sponsor (in Shares)	[1]		7,187,500
Net Income (Loss)					(74,235)	(74,235)
Balance at Dec. 31, 2024			$ 719	24,281	(74,235)	(49,235)
Balance (in Shares) at Dec. 31, 2024			7,187,500
Sale of 2,500,000 Private Placement Warrants				2,500,000		2,500,000
Allocated value of transaction costs to Public Warrants				(121,226)		(121,226)
Fair value of Public Warrants at issuance				3,162,500		3,162,500
Accretion of Class A Ordinary Shares to redemption amount				(5,565,555)	(9,937,162)	(15,502,717)
Net Income (Loss)					(7,403,644)	(7,403,644)
Balance at Dec. 31, 2025			$ 719		$ (17,415,041)	$ (17,414,322)
Balance (in Shares) at Dec. 31, 2025			7,187,500

[1] Includes up to 937,500 Class B Ordinary Shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (Note 5). On November 14, 2025, the Company consummated its Initial Public Offering and sold 28,750,000 Units, including 3,750,000 Units sold pursuant to the full exercise of the underwriter’s option to purchase additional Units to cover the over-allotment. As such, the 937,500 shares of Class B Ordinary Shares were no longer subject to forfeiture.